Nasdaq
$0.7427▼ 0.46%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $12.9MShares out 17.4M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
12- 10.13Pre-market26.10.13 21:304Ownership#●●●#●●●
IRIDEX CORP
According to the Form 4 filing for IRIDEX CORP, Novel Inspiration International Co., Ltd. and Lin Shih-Yao David reported a change in their beneficial ownership as of October 2, 2026. This filing serves as an official notification of changes in insider shareholdings.…more
$0.7427-0.46%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.7Pre-market26.10.07 19:104Ownership
IRIDEX CORP
Insider Lin Shih-Yao David of IRIDEX CORP reported a change in beneficial ownership of securities effective March 25, 2025. This filing serves as a standard Form 4 disclosure regarding insider equity transactions.…more
$0.7427-0.46%vs prev closeView filingShare - 10.7Pre-market26.10.07 19:084Ownership
IRIDEX CORP
Insider Lin Shih-Yao David of IRIDEX CORP filed a Form 4 statement regarding changes in beneficial ownership of securities, effective as of March 25, 2025. This filing serves as an official record of the insider's equity transaction.…more
$0.7427-0.46%vs prev closeView filingShare
11 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.12Pre-market26.10.12 20:00#●●●
Iridex Announces Positive Two-Year Clinical Results for MicroPulse Glaucoma Technology…more
A two-year independent study confirms that Iridex's MicroPulse technology effectively reduces intraocular pressure and medication burden in glaucoma patients. While the clinical data supports the therapy's long-term efficacy, the impact on immediate financial performance remains to be seen.…more
$0.7427-0.46%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.5Pre-market26.10.05 20:00
●●●●●●●● ●●●●● ●●●●●●
Iridex has completed the relocation of its manufacturing facility to San Jose, expecting approximately $600,000 in annualized cost savings. This move is part of the company's strategic plan to improve operational efficiency and profitability.…more
$0.7427-0.46%vs prev close - 8.18After-hours26.08.19 05:06
●●●●●●●● ●●●●● ●●●●●●
Iridex announced plans to transition production to contract manufacturers and relocate its headquarters to a lower-cost facility later this year. This strategic move aims to improve operational efficiency and reduce overall expenses.…more
$0.7427-0.46%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report